Ondine Biomedical Inc. (LON:OBI - Get Free Report) dropped 2.8% during mid-day trading on Tuesday . The company traded as low as C$10.12 and last traded at C$10.50. Approximately 54,047 shares were traded during trading, a decline of 83% from the average daily volume of 324,852 shares. The stock had previously closed at C$10.80.
Ondine Biomedical Price Performance
The company has a quick ratio of 8.26, a current ratio of 1.36 and a debt-to-equity ratio of 25.95. The stock has a market cap of C$71.90 million, a P/E ratio of -3.01 and a beta of 0.10. The business's 50-day simple moving average is C$10.99 and its two-hundred day simple moving average is C$8.61.
Insiders Place Their Bets
In other Ondine Biomedical news, insider Carolyn Cross bought 200,775 shares of the business's stock in a transaction on Thursday, January 30th. The stock was purchased at an average price of C$12.00 per share, for a total transaction of C$2,409,300.00. Company insiders own 36.69% of the company's stock.
About Ondine Biomedical
(
Get Free Report)
Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens.
Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings.
Further Reading
Before you consider Ondine Biomedical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ondine Biomedical wasn't on the list.
While Ondine Biomedical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
